Funding doubled for company working on breakthrough auto-immune disease therapeutics
A Paris-based biotech company developing products for auto-immune diseases, announced today (June 30) that it…
30/06/2022 - 3 minutes
funding
Osivax gets €10M influenza vaccine grant
A grant of €10 million ($10.5 million) has been secured by pharmaceutical company Osivax to…
23/06/2022 - 2 minutes
Shanghai biotech secures $80 million to advance products
A bio-manufacturing company based in Shanghai has bagged $80 million in funding to advance its…
23/06/2022 - 2 minutes
Millions invested for progression of Lyme disease vaccine
Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. …
22/06/2022 - 2 minutes
Biotech companies to benefit from Third Rock Ventures $1.1B fund
U.S. company Third Rock Ventures has closed Third Rock Ventures Fund VI, raising $1.1 billion. …
15/06/2022 - 2 minutes
New Forbion life sciences fund hits €470M
European life sciences venture capital firm Forbion, has announced the first €470M ($500M) close of…
09/06/2022 - 4 minutes
